Citation Impact
Citing Papers
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
2010 StandoutScience
Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases
2016 Standout
Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report
2007
Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial
2015
Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study
2015
2012
Medication Augmentation after the Failure of SSRIs for Depression
2006 Standout
Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial
2007 Standout
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
The Medical Management of Depression
2005
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Clinical and Demographic Factors Associated With DSM-IV Melancholic Depression
2006
Altered fecal microbiota composition in patients with major depressive disorder
2015 Standout
Conceptual convergence: increased inflammation is associated with increased basal ganglia glutamate in patients with major depression
2016
Remissions in maternal depression and child psychopathology: a STAR*D-child report.
2006
A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder
2011
Depression
2018 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder
2006
Major depressive disorder
2016 Standout
Stepped Care for Affective Disorders and Musculoskeletal Pain (SCAMP) study
2007
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
An Evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: A Sequenced Treatment Alternatives to Relieve Depression Trial Report
2005
EQUIP: Implementing chronic care principles and applying formative evaluation methods to improve care for schizophrenia: QUERI Series
2008
Glutamate receptor ion channels
2005 Standout
Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study
2014
CONSORT 2010 statement: extension to randomised pilot and feasibility trials
2016 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Collaborative Care for Bipolar Disorder: Part I. Intervention and Implementation in a Randomized Effectiveness Trial
2006
Effectiveness-implementation Hybrid Designs
2012 Standout
Comparison of St John's wort and imipramine for treating depression: randomised controlled trial
2000
A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report
2006
Inverse Association between Physical Inactivity and Mental Health in Men and Women
2005
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
2006 Standout
Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression study
2008
The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review
2010 Standout
Primary Versus Specialty Care Outcomes for Depressed Outpatients Managed with Measurement-Based Care: Results from STAR*D
2008
The HCL-32: Towards a self-assessment tool for hypomanic symptoms in outpatients
2005 Standout
Collaborative Care for Bipolar Disorder: Part II. Impact on Clinical Outcome, Function, and Costs
2006
Maternal Depression and Child Psychopathology: A Meta-Analytic Review
2010 Standout
Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed?
2005
Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression
2013
The Consensus Sleep Diary: Standardizing Prospective Sleep Self-Monitoring
2012 Standout
Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression
2010
The Use of Individually Tailored Environmental Supports to Improve Medication Adherence and Outcomes in Schizophrenia
2007
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model
2011
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis
2010 Standout
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
The Insomnia Severity Index: Psychometric Indicators to Detect Insomnia Cases and Evaluate Treatment Response
2011 Standout
St John's Wort for depression
1998
Enhancing Multiyear Guideline Concordance for Bipolar Disorder Through Collaborative Care
2009
A Computerized Decision Support System for Depression in Primary Care
2009
A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
2012
Long-term Effectiveness and Cost of a Systematic Care Program for Bipolar Disorder
2006
Depression in adolescence
2012 Standout
Effects of implementation of psychiatric guidelines on provider performance and patient outcome: systematic review
2007
Recommendations for a Standard Research Assessment of Insomnia
2006
Transdiagnostic neuroimaging in psychiatry: A review
2019
Major Depressive Disorder
2008 Standout
Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder
2004
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features
2005
IFN-Alpha-Induced Cortical and Subcortical Glutamate Changes Assessed by Magnetic Resonance Spectroscopy
2014
Systematic Use of Patient-Rated Depression Severity Monitoring: Is It Helpful and Feasible in Clinical Psychiatry?
2008
The molecular neurobiology of depression
2008 StandoutNature
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Mining electronic health records: towards better research applications and clinical care
2012 Standout
Applying Depression-Specific Change Concepts in a Collaborative Breakthrough Series
2005
The role of inflammation in depression: from evolutionary imperative to modern treatment target
2015 Standout
A brief cognitive assessment for use with schizophrenia patients in community clinics
2004
Depression in Older Adults
2009 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Meditation Programs for Psychological Stress and Well-being
2014 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Interventions for enhancing medication adherence
2008 Standout
Depression and Coronary Heart Disease
2008 Standout
A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report
2006
Printed educational materials: effects on professional practice and healthcare outcomes
2012 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Interventions for enhancing medication adherence
2014 Standout
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
The Interaction of Person-Affect-Cognition-Execution (I-PACE) model for addictive behaviors: Update, generalization to addictive behaviors beyond internet-use disorders, and specification of the process character of addictive behaviors
2019 Standout
Depressed Adolescents Treated with Exercise (DATE): A pilot randomized controlled trial to test feasibility and establish preliminary effect sizes
2013
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
2015
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
2000 Standout
Sleep Health: Can We Define It? Does It Matter?
2014 Standout
Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs
2010 Standout
Works of Bradley Witte being referenced
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
2004
Psychometric properties of the Quick Inventory of Depressive Symptomatology in adolescents
2010
Brain gray matter phenotypes across the psychosis dimension
2012
Itemized clinician ratings versus global ratings of symptom severity in patients with schizophrenia
2002
Texas Medication Algorithm Project, Phase 3 (TMAP-3)
2003
Texas Medication Algorithm Project, Phase 3 (TMAP-3)
2003
Clinical Results for Patients With Major Depressive Disorder in theTexas Medication Algorithm Project
2004
The Texas Medication Algorithm Project: Clinical Results for Schizophrenia
2004
Hippocampal Volume Is Reduced in Schizophrenia and Schizoaffective Disorder But Not in Psychotic Bipolar I Disorder Demonstrated by Both Manual Tracing and Automated Parcellation (FreeSurfer)
2014
Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes
2016
[Treatment of depressive symptoms with a high concentration hypericum preparation. A multicenter placebo-controlled double-blind study].
1995
Brief Psychiatric Rating Scale Expanded Version: How do new items affect factor structure?
2005